Irreversible enzyme inhibitors. CXLIV. Proteolytic enzymes. VII. Additonal active-site-directed irreversible inhibitors of trypsin derived from m- and p-(phenoxyalkoxy)benzamidines with a terminal sulfonyl fluoride. - Suppr | 超能文献

Irreversible enzyme inhibitors. CXLIV. Proteolytic enzymes. VII. Additonal active-site-directed irreversible inhibitors of trypsin derived from m- and p-(phenoxyalkoxy)benzamidines with a terminal sulfonyl fluoride.

作者信息

Baker B R, Erickson E H

出版信息

J Med Chem. 1969 Jan;12(1):112-7. doi: 10.1021/jm00301a029.

DOI:10.1021/jm00301a029

Abstract

摘要

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

文档翻译

学术文献翻译模型，支持多种主流文档格式。

相似文献

1

Irreversible enzyme inhibitors. CXLIV. Proteolytic enzymes. VII. Additonal active-site-directed irreversible inhibitors of trypsin derived from m- and p-(phenoxyalkoxy)benzamidines with a terminal sulfonyl fluoride.

J Med Chem. 1969 Jan;12(1):112-7. doi: 10.1021/jm00301a029.

2

Irreversible enzyme inhibitors. CXV. Proteolytic enzymes. V. Active-site-directed irreversible inhibitors of trypsin derived from p-(phenoxyalkoxy) benzamidines with a terminal sulfonyl fluoride.

J Med Chem. 1968 Mar;11(2):245-9. doi: 10.1021/jm00308a011.

3

Irreversible enzyme inhibitors. CXLV. Proteolytic enzymes. 8. Active-site-directed irreversible inhibitors of alpha-chymotrypsin derived from alpha-(2-carboxy-4-chlorophenoxy)acetamide bearing a terminal sulfonyl fluoride.

J Med Chem. 1969 Jan;12(1):118-22. doi: 10.1021/jm00301a030.

4

Irreversible enzyme inhibitors. 143. Active-site-directed irreversible inhibitors of dihydrofolic reductase derived from 5-(p-aminophenoxypropyl)-2,4-diamino-6-methylpyrimidine with a terminal sulfonyl fluoride.

J Med Chem. 1969 Jan;12(1):108-11. doi: 10.1021/jm00301a028.

5

Irreversible enzyme inhibitors. CXLII. Further studies on active-site-directed irreversible inhibitors of dihydrofolic reductase derived from 5-(p-Aminophenoxypropyl)-2,4,6-triaminopyrimidine bearing a terminal sulfonyl fluoride.

J Med Chem. 1969 Jan;12(1):104-7. doi: 10.1021/jm00301a027.

6

Irreversible enzyme inhibitors. CXXXVII. Active-site-directed irreversible inhibitors of dihydrofolic reductase derived from 6-(p-aminomethylphenoxymethyl)-2,4-diamino-5-(3,4-dichlorophenyl)pyrimidine bearing a terminal sulfonyl fluoride.

J Med Chem. 1969 Jan;12(1):86-8. doi: 10.1021/jm00301a022.

7

Irreversible enzyme inhibitors. 138. Active-site-directed irreversible inhibitors of dihydrofolic reductase derived from 6-(p-aminomethylphenethyl)-- 2,4-diamino-5-(3,4-dichlorophenyl)pyrimidine with a terminal sulfonyl fluoride.

J Med Chem. 1969 Jan;12(1):89-91. doi: 10.1021/jm00301a023.

8

[Quantum chemical studies on substituted benzamidines as inhibitors of the serine proteinases trypsin and thrombin].

Pharmazie. 1983 May;38(5):342-6.

9

Irreversible enzyme inhibitors. CXLI. Active-site-directed irreversible inhibitors of dihydrofolic reductase derived from 1-[p-(p-fluorosulfonylphenylureidomethyl)phenyl]-4,6-diamino-1,2-dihydro-2,2-dimethyl-s-triazine.

J Med Chem. 1969 Jan;12(1):101-4. doi: 10.1021/jm00301a026.

10

Irreversible enzyme inhibitors. CXIV. Proteolytic enzymes. IV. Additional active-site-directed irreversible inhibitors of alpha-chymotrypsin derived from phenoxyacetamides bearing a terminal sulfonyl fluoride.

J Med Chem. 1968 Mar;11(2):241-5. doi: 10.1021/jm00308a010.